Ampio Pharmaceuticals, Inc. AMPE
0.18 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.0052 Day range 0.0052
0.0052 52-week range 0.6435
- YTD
- +3,421.15%
- 1 year
- +3,421.15%
- Market cap
- 207.88K
- EPS (ttm)
- -722.91
- Shares out
- 1.14M
- Forward P/E
- -3.39
- YTD return
- +3421.15%
- 1-year return
- +3421.15%
- Volume
- 334
- Open
- 0.0052
- Previous close
- 0.1831
- Day's range
- 0.0052 – 0.0052
- 52-week range
- 0.0052 – 0.6435
- Beta
- 1.95
- Analysts
- Hold
- Earnings date
- Dec 24, 2024
2Y +0.1809 (+8222.73%)
Key statistics
- Enterprise value
- -2.97M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.08
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -5.37M
- Total cash
- 4.12M
- Total debt
- 451.00K
- Return on equity
- -113.96%
- Short % of float
- 2.94%
- 50-day average
- 1.49
- 200-day average
- 2.82
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
AMPE Revenue — quarterly 0
AMPE Net income — quarterly -2.05M
AMPE EPS — quarterly -2.48
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 1, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | -2.48 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -1.53 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -1.80 | — | — |
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ampiopharma.com
News
Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC) 
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) 
Ampio Pharmaceuticals (NYSE:AMPE) and Graybug Vision (NASDAQ:GRAY) Financial Contrast 
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation 
Ampio Announces Voluntary Delisting and SEC Deregistration 
12 Health Care Stocks Moving In Thursday's Intraday Session 
Ampio Provides Update on Results from Pre-IND Enabling Studies 
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions 
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on AMPE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAR-OR DAVID | Director | Stock Award(Grant) | Jan 3, 2021 | 92,800 |
| BUCHI J KEVIN | Director | Purchase | Jun 8, 2023 | 146,858 |
| CHEREVKA HOLLI | Chief Operating Officer | Stock Award(Grant) | Oct 10, 2021 | 500,000 |
| COELHO PHILIP H | Director | Sale | May 20, 2021 | 203,500 |
| GILES RICHARD B | Director | Stock Award(Grant) | Jan 3, 2021 | 367,121 |
| MACALUSO MICHAEL | Chief Executive Officer | Stock Award(Grant) | Oct 10, 2021 | 2,736,750 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.69% | 5,202 | 24.24K | Jun 29, 2023 |
| Private Capital Management LLC | 0.32% | 2,397 | 11.17K | Jun 29, 2023 |
| Two Sigma Securities, LLC | 0.20% | 1,507 | 7.02K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.19% | 1,425 | 6.64K | Jun 29, 2023 |
| Virtu Financial LLC | 0.17% | 1,265 | 5.89K | Jun 29, 2023 |
| Brighton Jones LLC | 0.16% | 1,230 | 5.73K | Jun 29, 2023 |